Filing Details
- Accession Number:
- 0001209191-13-022943
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-29 17:36:14
- Reporting Period:
- 2013-04-29
- Filing Date:
- 2013-04-29
- Accepted Time:
- 2013-04-29 17:36:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
742112 | Invacare Corp | IVC | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 952680965 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1314132 | C Dale Laporte | One Invacare Way Elyria OH 44035 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2013-04-29 | 1,000 | $12.24 | 22,126 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares | 20,000 | Indirect | By Trust |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Shares | Stock Option (Right to Buy) | $0.00 | 7,858 | 7,858 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
7,858 | 7,858 | Direct |
Footnotes
- Owned by the Reporting Person's Profit Sharing Trust Plan.
- No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
- The reporting person holds previously reported options to buy 7,858 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted on February 12, 2009, at an exercise price of $19.09 per share, will expire on February 13, 2019 and became or will become exercisable between March 31, 2010 and March 31, 2013.